CN101315386A - 高密度介质固相抗人球蛋白试剂盒 - Google Patents
高密度介质固相抗人球蛋白试剂盒 Download PDFInfo
- Publication number
- CN101315386A CN101315386A CNA2008100509533A CN200810050953A CN101315386A CN 101315386 A CN101315386 A CN 101315386A CN A2008100509533 A CNA2008100509533 A CN A2008100509533A CN 200810050953 A CN200810050953 A CN 200810050953A CN 101315386 A CN101315386 A CN 101315386A
- Authority
- CN
- China
- Prior art keywords
- antihuman globulin
- cell
- solid phase
- antibody
- red blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000006395 Globulins Human genes 0.000 title claims abstract description 44
- 108010044091 Globulins Proteins 0.000 title claims abstract description 44
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 24
- 239000007790 solid phase Substances 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 33
- 210000002966 serum Anatomy 0.000 claims abstract description 29
- 102000036639 antigens Human genes 0.000 claims abstract description 28
- 108091007433 antigens Proteins 0.000 claims abstract description 28
- 239000000427 antigen Substances 0.000 claims abstract description 27
- 238000001514 detection method Methods 0.000 claims abstract description 25
- 210000001772 blood platelet Anatomy 0.000 claims abstract description 20
- 238000005406 washing Methods 0.000 claims abstract description 12
- 241000700605 Viruses Species 0.000 claims abstract description 7
- 210000000601 blood cell Anatomy 0.000 claims abstract description 7
- 239000013642 negative control Substances 0.000 claims abstract description 5
- 239000013641 positive control Substances 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 35
- 238000002360 preparation method Methods 0.000 claims description 18
- 238000012216 screening Methods 0.000 claims description 16
- 125000006850 spacer group Chemical group 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000008363 phosphate buffer Substances 0.000 claims description 11
- 239000006249 magnetic particle Substances 0.000 claims description 10
- 230000004523 agglutinating effect Effects 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 210000000170 cell membrane Anatomy 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 230000005415 magnetization Effects 0.000 claims description 6
- 239000011859 microparticle Substances 0.000 claims description 6
- 210000002381 plasma Anatomy 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 230000005875 antibody response Effects 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 230000014670 detection of bacterium Effects 0.000 claims description 3
- MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 244000000010 microbial pathogen Species 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000004907 flux Effects 0.000 abstract description 2
- 238000005119 centrifugation Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 description 21
- 238000012360 testing method Methods 0.000 description 10
- 208000030507 AIDS Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000001788 irregular Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000002672 hepatitis B Diseases 0.000 description 4
- 208000006379 syphilis Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003617 erythrocyte membrane Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000003441 Transfusion reaction Diseases 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 101000767750 Carya illinoinensis Vicilin Car i 2.0101 Proteins 0.000 description 1
- 101000767759 Corylus avellana Vicilin Cor a 11.0101 Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 101000622316 Juglans regia Vicilin Jug r 2.0101 Proteins 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 101000767757 Pinus koraiensis Vicilin Pin k 2.0101 Proteins 0.000 description 1
- 101000767758 Pistacia vera Vicilin Pis v 3.0101 Proteins 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 238000009609 prenatal screening Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100509533A CN101315386A (zh) | 2008-07-11 | 2008-07-11 | 高密度介质固相抗人球蛋白试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100509533A CN101315386A (zh) | 2008-07-11 | 2008-07-11 | 高密度介质固相抗人球蛋白试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101315386A true CN101315386A (zh) | 2008-12-03 |
Family
ID=40106467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100509533A Pending CN101315386A (zh) | 2008-07-11 | 2008-07-11 | 高密度介质固相抗人球蛋白试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101315386A (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103323586A (zh) * | 2013-06-14 | 2013-09-25 | 中国科学院苏州生物医学工程技术研究所 | 一种血小板磁化免疫标记分析方法 |
CN103344755A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN103344772A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | Miltenberger血型抗体检测新方法 |
CN104569413A (zh) * | 2015-01-12 | 2015-04-29 | 中国科学院苏州生物医学工程技术研究所 | 一种血小板抗体检测的免疫纳米磁珠酶联免疫检测方法 |
CN108519483A (zh) * | 2018-05-26 | 2018-09-11 | 江苏力博医药生物技术股份有限公司 | 基于固相凝集法的血小板抗体检测试剂盒及其检测方法和应用 |
CN108680756A (zh) * | 2018-05-21 | 2018-10-19 | 中国科学院苏州生物医学工程技术研究所 | 一种不完全抗体检测试剂盒及检测方法 |
CN111398578A (zh) * | 2019-12-31 | 2020-07-10 | 珠海朗泰生物科技有限公司 | 一种布鲁氏菌抗体凝胶检测试剂盒 |
CN112204398A (zh) * | 2018-02-16 | 2021-01-08 | 迪亚加斯特公司 | 包括珠的体外诊断装置及其用途 |
CN112285361A (zh) * | 2020-09-27 | 2021-01-29 | 中国人民解放军空军军医大学 | 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂 |
CN112379100A (zh) * | 2020-10-13 | 2021-02-19 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN112666357A (zh) * | 2020-12-31 | 2021-04-16 | 宝锐生物科技泰州有限公司 | 一种抗血小板抗体检测信号制剂的制备方法、抗血小板抗体检测信号制剂及应用 |
CN112698043A (zh) * | 2020-12-31 | 2021-04-23 | 宝锐生物科技泰州有限公司 | 一种血小板抗体检测试剂盒、应用及检测方法 |
CN113156143A (zh) * | 2021-03-29 | 2021-07-23 | 山东威高集团医用高分子制品股份有限公司 | 血型不规则抗体特异性鉴定方法及其试剂 |
-
2008
- 2008-07-11 CN CNA2008100509533A patent/CN101315386A/zh active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103323586A (zh) * | 2013-06-14 | 2013-09-25 | 中国科学院苏州生物医学工程技术研究所 | 一种血小板磁化免疫标记分析方法 |
CN103344755A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN103344772A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | Miltenberger血型抗体检测新方法 |
CN103344772B (zh) * | 2013-07-19 | 2015-06-24 | 中国科学院苏州生物医学工程技术研究所 | Miltenberger血型抗体检测新方法 |
CN103344755B (zh) * | 2013-07-19 | 2015-06-24 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN104569413A (zh) * | 2015-01-12 | 2015-04-29 | 中国科学院苏州生物医学工程技术研究所 | 一种血小板抗体检测的免疫纳米磁珠酶联免疫检测方法 |
CN112204398A (zh) * | 2018-02-16 | 2021-01-08 | 迪亚加斯特公司 | 包括珠的体外诊断装置及其用途 |
CN108680756A (zh) * | 2018-05-21 | 2018-10-19 | 中国科学院苏州生物医学工程技术研究所 | 一种不完全抗体检测试剂盒及检测方法 |
CN108519483A (zh) * | 2018-05-26 | 2018-09-11 | 江苏力博医药生物技术股份有限公司 | 基于固相凝集法的血小板抗体检测试剂盒及其检测方法和应用 |
CN111398578A (zh) * | 2019-12-31 | 2020-07-10 | 珠海朗泰生物科技有限公司 | 一种布鲁氏菌抗体凝胶检测试剂盒 |
CN112285361A (zh) * | 2020-09-27 | 2021-01-29 | 中国人民解放军空军军医大学 | 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂 |
CN112285361B (zh) * | 2020-09-27 | 2023-12-05 | 中国人民解放军空军军医大学 | 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂 |
CN112379100A (zh) * | 2020-10-13 | 2021-02-19 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN112379100B (zh) * | 2020-10-13 | 2024-01-23 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN112666357A (zh) * | 2020-12-31 | 2021-04-16 | 宝锐生物科技泰州有限公司 | 一种抗血小板抗体检测信号制剂的制备方法、抗血小板抗体检测信号制剂及应用 |
CN112698043A (zh) * | 2020-12-31 | 2021-04-23 | 宝锐生物科技泰州有限公司 | 一种血小板抗体检测试剂盒、应用及检测方法 |
CN113156143A (zh) * | 2021-03-29 | 2021-07-23 | 山东威高集团医用高分子制品股份有限公司 | 血型不规则抗体特异性鉴定方法及其试剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101315386A (zh) | 高密度介质固相抗人球蛋白试剂盒 | |
US4960715A (en) | Diagnostic test methods | |
CN101387648A (zh) | 红细胞膜抗原磁珠试剂盒及在血型抗体检测方面的应用 | |
CN107643409A (zh) | 一种血型抗原芯片及其在红细胞意外抗体检测中的应用 | |
CN108680756A (zh) | 一种不完全抗体检测试剂盒及检测方法 | |
CN104360087A (zh) | 一种检测Miltenberger血型抗体的方法 | |
CN108344869A (zh) | 一种乙肝表面抗原化学发光免疫检测试剂盒及其应用 | |
Al‐Fawaz et al. | Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and β‐thalassemia major: possible transmission by blood transfusion | |
Lin et al. | Neonatal Alloimmune Thrombocytopenia in Taiwan Due to an Antibody against a Labile Component of HPA‐3a (Bak) | |
CN112698043A (zh) | 一种血小板抗体检测试剂盒、应用及检测方法 | |
CN113156143A (zh) | 血型不规则抗体特异性鉴定方法及其试剂 | |
Buakaew et al. | Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients | |
US20080206790A1 (en) | Assay for determining the presence or amount of newly synthesized antibodies | |
Mvere et al. | Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe. | |
CN101368965A (zh) | 一种检测巨细胞病毒IgM抗体的化学发光法免疫分析诊断试剂盒 | |
CN101493470A (zh) | 一种用于固相实验的u型板 | |
CN103706340B (zh) | 一种水性胶层析介质及用于检测的方法 | |
CN109725144A (zh) | 一种jmh血型抗原芯片及其在红细胞意外抗体检测中的应用 | |
CN1282871A (zh) | 微柱凝胶法血小板血型抗原抗体检测技术和试剂盒 | |
EP0022669B1 (en) | Method and reagent for blood typing and method for preparing this reagent | |
CN201402265Y (zh) | 一种用于固相实验的u型板 | |
EP0328588B1 (en) | DETERMINATION OF IgM ANTIBODIES | |
CN109725145A (zh) | 一种Inb血型抗原芯片及其在红细胞意外抗体检测中的应用 | |
US5238814A (en) | IgG antigen-antibody complex for quick Rh blood typing | |
CN108318681A (zh) | 一种库波热病毒的检测试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGCHUN BLOOD BIO-TECH CO., LTD. Free format text: FORMER OWNER: LI YONG Effective date: 20110707 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130012 NO. 433, CHENGUANG STREET, HIGH-TECH. DEVELOPMENT ZONE, JILIN CITY, JILIN PROVINCE TO: 130012 NO. 3255, QIANJIN STREET, CHANGCHUN CITY, JILIN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110707 Address after: 130012 No. 3255 Qianjin Street, Jilin, Changchun Applicant after: Changchun Brother Biotech Co., Ltd. Address before: 130012 No. 433 Chenguang street, hi tech Development Zone, Jilin, Jilin Applicant before: Li Yong |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20081203 |